By using modified mRNA technology similar to the approach used in developing COVID-19 vaccines, the researchers successfully 'awakened' these dormant stem cells, enabling them to divide in a controlled manner.
Israel’s BiolineRx has reported positive results from Phase II trials of its BL-8040 treatment in relapsed or refractory acute myeloid leukemia and researchers at the Hebrew University of Jerusalem have uncovered a key gene responsible for ovary development.
Français
Español
English
Portuguese
